| scholarly article | Q13442814 |
| P2093 | author name string | J Yang | |
| A Vassil | |||
| G F Sullivan | |||
| J Bash-Babula | |||
| J M Yang | |||
| W N Hait | |||
| P2860 | cites work | Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo | Q28253554 |
| p53-dependent apoptosis modulates the cytotoxicity of anticancer agents | Q29615031 | ||
| Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a. | Q35207550 | ||
| Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis | Q35933390 | ||
| P-glycoprotein is not expressed in a majority of colorectal carcinomas and is not regulated by mutant p53 in vivo | Q36081542 | ||
| Wild-type p53 is a cell cycle checkpoint determinant following irradiation | Q37152060 | ||
| Beta-lapachone-mediated apoptosis in human promyelocytic leukemia (HL-60) and human prostate cancer cells: a p53-independent response | Q39495999 | ||
| Transcriptional suppression of multidrug resistance-associated protein (MRP) gene expression by wild-type p53. | Q40985823 | ||
| Transport function and substrate specificity of multidrug resistance protein | Q41015195 | ||
| The role of MAP4 expression in the sensitivity to paclitaxel and resistance to vinca alkaloids in p53 mutant cells. | Q41046921 | ||
| p53 induced by ionizing radiation mediates DNA end-jointing activity, but not apoptosis of thyroid cells | Q41116866 | ||
| Carbamoylation of glutathione reductase by N,N-bis(2-chloroethyl)-N- nitrosourea associated with inhibition of multidrug resistance protein (MRP) function | Q41120241 | ||
| Wild-type p53 negatively regulates the expression of a microtubule-associated protein | Q41148864 | ||
| Modulation of activity of the promoter of the human MDR1 gene by Ras and p53. | Q41643433 | ||
| The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. | Q42282466 | ||
| Transactivation of the human multidrug resistance (MDR1) gene promoter by p53 mutants. | Q42492575 | ||
| Structure and in vitro substrate specificity of the murine multidrug resistance-associated protein | Q42807961 | ||
| ATP-dependent glutathione disulphide transport mediated by the MRP gene-encoded conjugate export pump | Q42981150 | ||
| Multidrug resistance mediated by the ATP-binding cassette transporter protein MRP. | Q47732687 | ||
| The expression of drug resistance gene products during the progression of human prostate cancer | Q47975595 | ||
| bcl-2 suppresses expression of p21WAF1/CIP1 in breast epithelial cells. | Q51120707 | ||
| Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia. | Q53429823 | ||
| Multidrug resistance-associated protein (MRP) expression is correlated with expression of aberrant p53 protein in colorectal cancer. | Q54074261 | ||
| Multidrug resistance-associated protein and mutant p53 protein expression in non-small cell lung cancer. | Q54115157 | ||
| The immunohistochemical localization of drug-metabolizing enzymes in prostate cancer. | Q54161993 | ||
| Chemical carcinogenesis, mutagenesis, and teratogenesis | Q71711140 | ||
| A temperature sensitive mutant of the human p53, Val138, arrests rat cell growth without induced expression of cip1/waf1/sdi1 after temperature shift-down | Q72263985 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prostate cancer | Q181257 |
| multiple drug resistance | Q643839 | ||
| P304 | page(s) | 1261-1267 | |
| P577 | publication date | 2000-05-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Regulation of expression of the multidrug resistance protein MRP1 by p53 in human prostate cancer cells | |
| P478 | volume | 105 |
| Q38986437 | A cisplatin-resistant head and neck cancer cell line with cytoplasmic p53(mut) exhibits ATP-binding cassette transporter upregulation and high glutathione levels. |
| Q39825726 | A role for p53 in the regulation of extracellular matrix metalloproteinase inducer in human cancer cells |
| Q35621694 | Aberrant regulation of the MRP3 gene in non-small cell lung carcinoma |
| Q92633975 | Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer |
| Q34580489 | Cancer chemoresistance: the relationship between p53 and multidrug transporters |
| Q53886209 | Coexpression of p53 protein and MDR functional phenotype in leukemias: the predominant association in chronic myeloid leukemia. |
| Q37245894 | Comparison of 2,2-bis(bromomethyl)-1,3-propanediol induced genotoxicity in UROtsa cells and primary rat hepatocytes: relevance of metabolism and oxidative stress |
| Q52719561 | Delivery of siRNA in vitro and in vivo using PEI-capped porous silicon nanoparticles to silence MRP1 and inhibit proliferation in glioblastoma. |
| Q32139388 | Differential sensitivities of the MRP gene family and gamma-glutamylcysteine synthetase to prooxidants in human colorectal carcinoma cell lines with different p53 status |
| Q35048750 | Drug transport proteins in the liver |
| Q51657861 | Evaluation of MRP1-5 gene expression in cystic fibrosis patients homozygous for the delta F508 mutation. |
| Q92128600 | Gliotoxin Enhances Autophagic Cell Death via the DAPK1-TAp63 Signaling Pathway in Paclitaxel-Resistant Ovarian Cancer Cells |
| Q38295189 | Hammerhead ribozyme against gamma-glutamylcysteine synthetase sensitizes human colonic cancer cells to cisplatin by down-regulating both the glutathione synthesis and the expression of multidrug resistance proteins |
| Q24534121 | High cellular accumulation of sulphoraphane, a dietary anticarcinogen, is followed by rapid transporter-mediated export as a glutathione conjugate |
| Q45841090 | Human C-reactive protein does not bind to fcγRIIa on phagocyti cells |
| Q38199535 | Importance of ABCC1 for cancer therapy and prognosis. |
| Q40752034 | Influence of redox-active compounds and PXR-activators on human MRP1 and MRP2 gene expression |
| Q28582121 | Involvement of cAMP-response element binding protein-1 in arachidonic acid-induced vascular smooth muscle cell motility |
| Q38626237 | MRP1 and its role in anticancer drug resistance |
| Q35791530 | MYCN enhances P-gp/MDR1 gene expression in the human metastatic neuroblastoma IGR-N-91 model |
| Q42455985 | MYCN-mediated regulation of the MRP1 promoter in human neuroblastoma. |
| Q43185454 | Modulation of MDR/MRP by wild-type and mutant p53. |
| Q48035751 | Multidrug resistance proteins in tuberous sclerosis and refractory epilepsy |
| Q40184405 | Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase/Akt signal transduction network in human acute myelogenous leukemia blasts |
| Q37218229 | Multidrug-resistant protein-3 gene regulation by the transcription factor Nrf2 in human bronchial epithelial and non-small-cell lung carcinoma. |
| Q39227845 | Multiple mechanisms are involved in 6-gingerol-induced cell growth arrest and apoptosis in human colorectal cancer cells. |
| Q40788757 | Mutant p53 cooperates with ETS and selectively up-regulates human MDR1 not MRP1. |
| Q24614785 | Notch1 regulates the expression of the multidrug resistance gene ABCC1/MRP1 in cultured cancer cells |
| Q34572110 | Pharmacogenetics and cancer therapy |
| Q37163352 | Pharmacogenetics of drug metabolizing enzymes and transporters: effects on pharmacokinetics and pharmacodynamics of anticancer agents |
| Q36691571 | Portrait of multifaceted transporter, the multidrug resistance-associated protein 1 (MRP1/ABCC1). |
| Q57811412 | Predicting Tumor Sensitivity to Chemotherapeutic Drugs in Oral Squamous Cell Carcinoma Patients |
| Q35690177 | Regulation of hepatic ABCC transporters by xenobiotics and in disease states |
| Q44320990 | Regulation of the MDR1 promoter by E2F1 and EAPP. |
| Q36995054 | Targeting prostate cancer based on signal transduction and cell cycle pathways. |
| Q91692891 | Tetrandrine Interaction with ABCB1 Reverses Multidrug Resistance in Cancer Cells Through Competition with Anti-Cancer Drugs Followed by Downregulation of ABCB1 Expression |
| Q26799364 | The Regulation of Steroid Action by Sulfation and Desulfation |
| Q35818407 | The Roles of MicroRNAs in Breast Cancer |
| Q37182764 | The individualization of cancer therapy: the unexpected role of p53. |
| Q39656316 | The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation |
| Q35567283 | Transcriptional regulation of ABC drug transporters |
| Q36525551 | Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins |
| Q80510495 | Tubulin-targeting agents |
| Q81086242 | Tubulin-targeting agents |
| Q47245509 | Unexpected Lower Expression of Oncoprotein Gankyrin in Drug Resistant ABCG2 Overexpressing Breast Cancer Cell Lines |
| Q34204238 | Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters |
| Q33516216 | Visualization and enrichment of live putative cancer stem cell populations following p53 inactivation or Bax deletion using non-toxic fluorescent dyes. |
| Q87600962 | WITHDRAWN: Bronchial-pulmonary adenocarcinoma subtyping relates with different molecular pathways |
| Q38867141 | γ-Tocotrienol and 6-Gingerol in Combination Synergistically Induce Cytotoxicity and Apoptosis in HT-29 and SW837 Human Colorectal Cancer Cells. |
Search more.